News

BarkerGilmore Welcomes David Rowan as Strategic Advisor

BarkerGilmore Welcomes David Rowan as Strategic Advisor

David Rowan's New Role at BarkerGilmore

In a significant move, BarkerGilmore LLC has appointed David Rowan as a Strategic Advisor and Leadership Development Coach, following his impressive 30-year tenure at one of the world’s leading healthcare organizations. His extensive experience in healthcare and corporate governance will greatly enrich BarkerGilmore's services.

A Dynamic Career at Cleveland Clinic

Mr. Rowan recently concluded an extraordinary career as the Chief Legal Officer at Cleveland Clinic, known for its commitment to excellence in healthcare. With more than 81,000 employees and numerous facilities, this institution generates over $14.5 billion in operating revenue. His leadership involved overseeing a dedicated team of 50 legal professionals, managing complex legal functions across the organization.

Innovations and Achievements

During his impactful career at Cleveland Clinic, Mr. Rowan played a crucial role in the establishment of international branches, including Cleveland Clinic London and Abu Dhabi. His contributions extended to collaborating with technology leaders, enabling the organization to stay at the forefront of healthcare innovation.

As Chief Governance Officer, he was pivotal in guiding the Cleveland Clinic Board through significant changes and strategic discussions, notably during the transition of leadership under three different CEOs.

Strategic Advisory at BarkerGilmore

At BarkerGilmore, Mr. Rowan will focus primarily on the healthcare and non-profit sectors, using his vast knowledge to assist organizations and senior leaders through various capabilities. These include executive coaching, compliance, and governance strategies. His insight into the healthcare sector's evolving landscape will provide clients with a competitive edge when it comes to managing legal and compliance talent.

Bob Barker's Statement

Bob Barker, Managing Partner of BarkerGilmore, expressed great enthusiasm about David Rowan's appointment, noting that his experience in governance and leadership will significantly benefit their clients. The firm aims to leverage Mr. Rowan’s expertise to enhance its coaching and advisory services, ensuring that clients receive top-notch guidance in navigating today’s complex business environment.

Vision for the Future

David Rowan believes that sharing his wealth of experiences will help others tackle common management challenges while also fostering innovation within both healthcare and broader industries. He sees BarkerGilmore's tailored approach as a valuable asset for organizations aiming to elevate their in-house legal and compliance teams.

The healthcare sector's rapid transformation requires organizations to adapt quickly; Mr. Rowan aims to aid them in utilizing their legal and compliance resources as strategic advantages. He is excited about collaborating with BarkerGilmore to make impactful changes in this dynamic environment.

Prior Experience and Expertise

Before his role at Cleveland Clinic, Mr. Rowan was with Squire, Sanders & Dempsey, where he co-led the healthcare practice. His longstanding commitment to social justice is evident through his work with the Diversity Center of Northeast Ohio.

A recognized authority on healthcare law and governance, Mr. Rowan has often shared his insights through speaking engagements on related subjects. He has achieved notable academic success, graduating magna cum laude from Georgetown University Law Center and summa cum laude from the University of Toledo.

About BarkerGilmore

Founded in 2006, BarkerGilmore specializes in executive search, coaching, and leadership development. The firm is dedicated to building high-performing legal and compliance teams that help drive business success. With a unique combination of skilled consultants and seasoned industry professionals, BarkerGilmore creates comprehensive solutions tailored to meet the evolving needs of organizations.

Measuring success through client satisfaction and diversity efforts, BarkerGilmore is well-equipped to support clients in achieving long-term success. To learn more about what they offer, visit their website.

Frequently Asked Questions

1. What is David Rowan's new position at BarkerGilmore?

David Rowan has been appointed as a Strategic Advisor and Leadership Development Coach, focusing on healthcare and non-profit sectors.

2. What was Mr. Rowan's role at Cleveland Clinic?

He served as the Chief Legal Officer, overseeing a law department and managing all legal functions within the organization.

3. How will Mr. Rowan's experience benefit BarkerGilmore clients?

His background in governance and legal leadership will enhance coaching and advisory services, providing strategic insights to clients.

4. What sectors will Mr. Rowan primarily focus on at BarkerGilmore?

He will primarily advise organizations in the healthcare and non-profit sectors.

5. What is BarkerGilmore known for?

BarkerGilmore is recognized for its executive search, coaching, and leadership development services, specializing in legal and compliance teams.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading